Discovery of potential neurodegenerative inhibitors in Alzheimer’s disease by casein kinase 1 structure-based virtual screening
- 22 August 2017
- journal article
- research article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 26 (12) , 3274-3285
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2010/14929-3)
This publication has 44 references indexed in Scilit:
- New molecular scaffolds for the design of Alzheimer’s acetylcholinesterase inhibitors identified using ligand- and receptor-based virtual screeningMedicinal Chemistry Research, 2012
- Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural DatabaseJournal of Chemical Information and Modeling, 2010
- Targeting protein kinases in central nervous system disordersNature Reviews Drug Discovery, 2009
- Regulation of Alzheimer's disease amyloid-β formation by casein kinase IProceedings of the National Academy of Sciences, 2007
- BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinitiesNucleic Acids Research, 2006
- Improved protein–ligand docking using GOLDProteins: Structure, Function, and Bioinformatics, 2003
- Crystal Structure of a Conformation-selective Casein Kinase-1 InhibitorJournal of Biological Chemistry, 2000
- Knowledge-Based Expert Systems for Toxicity and Metabolism Prediction: DEREK, StAR and METEORSAR and QSAR in Environmental Research, 1999
- Three-dimensional Structure of Mammalian Casein Kinase I: Molecular Basis for Phosphate RecognitionJournal of Molecular Biology, 1996
- Phosphorylation of τ Protein by Casein Kinase‐1 Converts It to an Abnormal Alzheimer‐Like StateJournal of Neurochemistry, 1995